132 related articles for article (PubMed ID: 31079708)
1. Introduction to Issue on Yttrium-90 Radioembolization.
Gandhi RT
Tech Vasc Interv Radiol; 2019 Jun; 22(2):41. PubMed ID: 31079708
[No Abstract] [Full Text] [Related]
2. Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.
Gordon AC; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1316-1319. PubMed ID: 27566423
[No Abstract] [Full Text] [Related]
3. Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.
Hamoui N; Minocha J; Memon K; Sato K; Ryu R; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2013 Nov; 24(11):1743-5. PubMed ID: 24160828
[No Abstract] [Full Text] [Related]
4. Acute Biliary Obstruction after Transarterial Radioembolization with Yttrium-90.
Ghosn M; Mulé S; Chalaye J; Tacher V; Calderaro J; Luciani A; Amaddeo G
J Vasc Interv Radiol; 2019 Dec; 30(12):2043-2045. PubMed ID: 31668969
[No Abstract] [Full Text] [Related]
5. Segmental Pneumonitis after Radioembolization.
Jaureguizar JIB; Sancho L; Páramo M; Rodríguez-Fraile M; Chopitea A; Benito A; Iñarrairaegui M; Sangro B
J Vasc Interv Radiol; 2018 Sep; 29(9):1305-1306. PubMed ID: 30146206
[No Abstract] [Full Text] [Related]
6. Focus on Uniformity, Not Dose: The Folly of Yttrium-90 Transarterial Radioembolization Dose-Escalation Studies.
Nuffer Z
J Vasc Interv Radiol; 2024 Jun; 35(6):918-919. PubMed ID: 38447769
[No Abstract] [Full Text] [Related]
7. The Utility of Unilobar Technetium-99m Macroaggregated Albumin to Predict Pulmonary Toxicity In Bilobar Hepatocellular Carcinoma prior to Yttrium-90 Radioembolization.
Kallini JR; Gabr A; Kulik L; Salem R; Lewandowski RJ
J Vasc Interv Radiol; 2016 Sep; 27(9):1453-1456. PubMed ID: 27566430
[No Abstract] [Full Text] [Related]
8. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis.
Kim AY; Frantz S; Brower J; Akhter N
J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469
[TBL] [Abstract][Full Text] [Related]
9. Temporary Balloon Occlusion for Hepatic Arterial Flow Redistribution during Yttrium-90 Radioembolization.
Meek J; Fletcher S; Gauss CH; Bezold S; Borja-Cacho D; Meek M
J Vasc Interv Radiol; 2019 Aug; 30(8):1201-1206. PubMed ID: 31155499
[TBL] [Abstract][Full Text] [Related]
10. Combination Ipsilateral Lobar and Segmental Radioembolization Using Glass Yttrium-90 Microspheres for Treatment of Multifocal Hepatic Malignancies.
Arslan B; Padela MT; Madassery S; Masrani A; Tasse J; Supanich M; Ahmed O
J Vasc Interv Radiol; 2018 Aug; 29(8):1110-1116. PubMed ID: 30055781
[TBL] [Abstract][Full Text] [Related]
11. Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: an alternative to portal vein embolization?
Teo JY; Goh BK
World J Gastroenterol; 2015 Mar; 21(11):3170-3. PubMed ID: 25805922
[TBL] [Abstract][Full Text] [Related]
12. Histological changes in nontumoral liver secondary to radioembolization of hepatocellular carcinoma with yttrium 90-impregnated microspheres: report of two cases.
Dhingra S; Schwartz M; Kim E; Mabel Ko H; Ward SC; Fiel MI; Thung SN
Semin Liver Dis; 2014 Nov; 34(4):465-8. PubMed ID: 25369308
[TBL] [Abstract][Full Text] [Related]
13. Cholecystoduodenal fistula after yttrium-90 radioembolization.
Patel NM; Yuan J; David J
J Clin Gastroenterol; 2010 Sep; 44(8):594-5. PubMed ID: 20216427
[No Abstract] [Full Text] [Related]
14. Angiogenic Response following Radioembolization: Results from a Randomized Pilot Study of Yttrium-90 with or without Sorafenib.
Lewandowski RJ; Andreoli JM; Hickey R; Kallini JR; Gabr A; Baker T; Kircher S; Salem R; Kulik L
J Vasc Interv Radiol; 2016 Sep; 27(9):1329-1336. PubMed ID: 27266362
[TBL] [Abstract][Full Text] [Related]
15. Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.
Memon K; Kuzel TM; Vouche M; Atassi R; Lewandowski RJ; Salem R
Melanoma Res; 2014 Jun; 24(3):244-51. PubMed ID: 24638152
[TBL] [Abstract][Full Text] [Related]
16. Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.
Lea WB; Tapp KN; Tann M; Hutchins GD; Fletcher JW; Johnson MS
J Vasc Interv Radiol; 2014 Oct; 25(10):1595-603. PubMed ID: 25156647
[TBL] [Abstract][Full Text] [Related]
17. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
[TBL] [Abstract][Full Text] [Related]
18. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
[TBL] [Abstract][Full Text] [Related]
19. Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
Jia Z; Paz-Fumagalli R; Frey G; Sella DM; McKinney JM; Wang W
J Gastroenterol Hepatol; 2017 Sep; 32(9):1617-1623. PubMed ID: 28132407
[TBL] [Abstract][Full Text] [Related]
20. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review.
Wright CL; Werner JD; Tran JM; Gates VL; Rikabi AA; Shah MH; Salem R
J Vasc Interv Radiol; 2012 May; 23(5):669-74. PubMed ID: 22525023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]